Results 201 to 210 of about 1,419,720 (263)

Real-World Utilisation and Cost Trends of Mineralocorticoid Receptor Antagonists in England: A Population-Level Prescribing Analysis From 2022 to 2025. [PDF]

Cardiovasc Ther
Kow CS, Hasan SS, Thiruchelvam K, Zaihan AF.   +3 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists for acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials. [PDF]

Open Heart
Ang SP, Chia JE, Lima BB, Iglesias J, Lee E, Krittanawong C, Alam M, Mukherjee D.   +7 more
europepmc   +1 more source

Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Chen YH, Fang YW, Chen MT, Liou HH, Tsai MH.   +4 more
europepmc   +1 more source

Aldosterone Breakthrough for the Prediction of Treatment Response to Mineralocorticoid Receptor Antagonists. [PDF]

Kidney Med
Imcaoudene AR, Najjar C, Marques P, Tsoukas MA, Sharma A, Mavrakanas TA.   +5 more
europepmc   +1 more source

Divergent Renal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Nondiabetic Kidney Disease.

Kidney Blood Press Res
Chen R, Zhang J, Chen J, Xie T, Xu Y, Hu Z, Chen J.   +6 more
europepmc   +1 more source

Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Wu J, Pei Y, Wu J, Huang Y.
europepmc   +1 more source

Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real-World Evidence From a Multicenter Cohort Study. [PDF]

J Am Heart Assoc
Wu JY, Tseng KJ, Lin YM.
europepmc   +1 more source

Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA) - a clinical research protocol for a randomised controlled trial. [PDF]

BMJ Open
Merabtine A, Leung AA, Kline GA, Dubrofsky L, Hundemer GL, Goupil R.   +5 more
europepmc   +1 more source

Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism. [PDF]

BMC Endocr Disord
Thipbumrung S, Manosroi W.
europepmc   +1 more source

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases. [PDF]

ESC Heart Fail
Wang J, Zheng M, Yang Y, Zhang L, Wulasihan M.   +4 more
europepmc   +1 more source